Robert Miller, MD | |
2160 S First Ave, (1211 Roosevelt Rd., Maywood, Il. 60153), Maywood, IL 60153 | |
(708) 531-5200 | |
(708) 531-5201 |
Full Name | Robert Miller |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 26 Years |
Location | 2160 S First Ave, Maywood, Illinois |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417937004 | NPI | - | NPPES |
36103949 | Medicaid | IL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 36103949 (Illinois) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Loyola Medicine Home Care | Oak brook, IL | Home health agency |
Loyola University Medical Center | Maywood, IL | Hospital |
Gottlieb Memorial Hospital | Melrose park, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Loyola University Medical Center | 3779488903 | 863 |
News Archive
Preterm babies are born at a higher rate in the United States than in 130 other countries of the world, including many poorer nations, according to the just-released report Born Too Soon: The Global Action Report on Preterm Birth.
In written testimony, Jonathan Blum, deputy administrator of the Centers For Medicare & Medicaid Services, says the changes are needed to head off cost increases, but an industry-sponsored study argues some of the changes could cost taxpayers more.
A promising cancer treatment drug can restore function of a heart en route to failure from high blood pressure, researchers at UT Southwestern Medical Center have found.
Spark Therapeutics and Genable Technologies announced today that they have entered into a collaboration agreement for Genable's lead therapeutic to treat rhodopsin-linked autosomal dominant retinitis pigmentosa (RHO adRP), GT038.
› Verified 2 days ago
Entity Name | Loyola University Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336159961 PECOS PAC ID: 3779488903 Enrollment ID: O20031202000027 |
News Archive
Preterm babies are born at a higher rate in the United States than in 130 other countries of the world, including many poorer nations, according to the just-released report Born Too Soon: The Global Action Report on Preterm Birth.
In written testimony, Jonathan Blum, deputy administrator of the Centers For Medicare & Medicaid Services, says the changes are needed to head off cost increases, but an industry-sponsored study argues some of the changes could cost taxpayers more.
A promising cancer treatment drug can restore function of a heart en route to failure from high blood pressure, researchers at UT Southwestern Medical Center have found.
Spark Therapeutics and Genable Technologies announced today that they have entered into a collaboration agreement for Genable's lead therapeutic to treat rhodopsin-linked autosomal dominant retinitis pigmentosa (RHO adRP), GT038.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Robert Miller, MD 2160 S First Ave, (1211 Roosevelt Rd., Maywood, Il. 60153), Maywood, IL 60153 Ph: (708) 531-5200 | Robert Miller, MD 2160 S First Ave, (1211 Roosevelt Rd., Maywood, Il. 60153), Maywood, IL 60153 Ph: (708) 531-5200 |
News Archive
Preterm babies are born at a higher rate in the United States than in 130 other countries of the world, including many poorer nations, according to the just-released report Born Too Soon: The Global Action Report on Preterm Birth.
In written testimony, Jonathan Blum, deputy administrator of the Centers For Medicare & Medicaid Services, says the changes are needed to head off cost increases, but an industry-sponsored study argues some of the changes could cost taxpayers more.
A promising cancer treatment drug can restore function of a heart en route to failure from high blood pressure, researchers at UT Southwestern Medical Center have found.
Spark Therapeutics and Genable Technologies announced today that they have entered into a collaboration agreement for Genable's lead therapeutic to treat rhodopsin-linked autosomal dominant retinitis pigmentosa (RHO adRP), GT038.
› Verified 2 days ago
Eva Bading, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2160 S First Ave, (1211 Roosevelt Rd. ), Maywood, IL 60153 Phone: 708-531-5200 Fax: 708-531-5201 | |
Michael Gregory Mank, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-5446 | |
Chelsea Leigh Fournier, Family Medicine Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 586-588-0217 | |
Kenneth Kin Kan Chan, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 2160 S. First Avenue, Loyola Outpatient Center, 4300, Maywood, IL 60153 Phone: 708-216-6006 Fax: 708-216-2683 | |
Peter Lyson, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-783-3913 | |
Dr. Jessica Carrie Dingman Mcintyre, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-9000 | |
Dr. Sudheer Earanky, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-4533 |